Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.
Lu
Hua
H
Lu
Shi-Feng
SF
Shen
Wen-Yi
WY
Hong
Ming
M
Zhang
Jian-Fu
JF
Wang
Li-Xia
LX
Yang
Hui
H
Li
Jian-Yong
JY
D015250:Aclarubicin / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D005434:Flow Cytometry; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D045164:Mesenchymal Stem Cell Transplantation; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000628:therapy*; D012074:Remission Induction; D014184:Transplantation, Homologous
D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D015250:Aclarubicin